ArticleMedical journal of the Islamic Republic of Iran2025
Evaluating the Efficacy of Longitudinal Coagulation Biomarkers to Predict in-Hospital Death in Comatose TBI Patients: A Time-Dependent Roc Curve Approach.
Article in Medical journal of the Islamic Republic of Iran, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Coagulopathy is a significant risk factor for in-hospital mortality in patients with traumatic brain injury (TBI). Timely monitoring of coagulation biomarkers (CB) may be crucial for predicting TBI patient prognosis. The objective of this study was to assess the time-dependent accuracy of conventional CB in predicting TBI patient outcomes using an ROC curve based on a joint longitudinal and survival data analysis. Methods: A retrospective cohort study was conducted on 132 out of 604 TBI patients admitted to Shohada-E-Tajrish Hospital in Tehran, Iran, between 2018 and 2020. CB (INR, PT, and aPTT) every 24 hours, and patient outcomes (death or survival) up to 10 days after admission were recorded. After choosing the best joint model longitudinal and survival data, the time-dependent ROC curve analysis was used, and the AUC, sensitivity, and specificity values were calculated in R 4.1.0. Results: In this study, non-surviving TBI patients had significantly higher mean aPTT, PT, and INR values than survivors. In addition, aPTT demonstrated the strongest time-dependent predictive power (AUC>0.7) for up to the fourth day after admission, while PT and INR had AUC>0.7 for up to the third day after admission. Conclusion: This study highlights that conventional coagulation biomarkers (aPTT, PT, and INR) demonstrate significant time-dependent efficacy in predicting in-hospital mortality in comatose TBI patients within the first three days of admission. Early recognition and proper management of coagulopathy are essential to improve outcomes and reduce morbidity and mortality in these patients during three days of admission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.